{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001799448","name":"Aligos Therapeutics, Inc.","summary":"Aligos Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for liver diseases and viral infections. Key pipeline assets include pevifoscorvir sodium (CAM-E) for chronic HBV infection in Phase 2 B-SUPREME study, ALG-055009 (THR-beta agonist) for MASH and obesity in Phase 2a, and ALG-097558 (coronavirus 3CL protease inhibitor) in Phase 2 for COVID-19. The company also maintains preclinical ASO platforms for HBV and HDV.","people":[],"products":[{"name":"Pevifoscorvir sodium (ALG-000184)","type":"platform","description":"Potential best/first-in-class Capsid Assembly Modulator-E (CAM-E) for chronic HBV infection, in Phase 2 B-SUPREME study."},{"name":"ALG-055009","type":"platform","description":"Potential best-in-class thyroid hormone receptor beta agonist for MASH and obesity, completed Phase 2a."},{"name":"ALG-097558","type":"platform","description":"Ritonavir-free pan-coronavirus 3CL protease inhibitor for COVID-19, currently in Phase 2 clinical study."},{"name":"ALG-170675","type":"platform","description":"Next-generation ASO for HBV targeting HBsAg mRNA destruction and TLR-8 agonism; selected for IND-enabling studies with partner Amoytop."}],"partnerships":[{"partner_name":"Xiamen Amoytop Biotech Co., Ltd.","partnership_type":"development","description":"Partner funding development of ALG-170675 ASO in China; Amoytop retains rights in China, Taiwan, Hong Kong, and Macau.","start_date":null},{"partner_name":"Emory University (Professor Raymond Schinazi laboratory)","partnership_type":"licensing","description":"In-licensed lead CAM-E drug candidate GLP26 and associated IP in 2018, which was optimized into pevifoscorvir sodium.","start_date":null}],"affiliations":[],"origin":{"leaf":"b380b73f781625fa9b37cce180219455e9d6861ed9077d373d4c7a5da17c0f75","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"a8fa9a7c36a22bb746852db2f413c4b2311a9c2c85094a4564102cf002ac2429","parent":"63c9411c0c562fc1fd53434c04cd7e2edcdb1f835b05c23e4adebceea9767dea","source":"0001193125-26-092614","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":259,"hourly_limit":500,"remaining":241,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}